Quelling inflammation frees up energy so your body can function more efficiently
This decision reverses a previous ruling that placed approximately 19 peptides on the more restrictive Category 2 list, effectively banning their use in compounded medications due to potential significant safety risks. The reversal came after significant debate and legal challenges from medical providers and pharmacy groups, who argued that the FDA had not presented sufficient evidence to justify the ban
Zhang L, Naiki Y, Chang YT, Haider A, Copeland K, Lustig R, Morgan G, Mowat D, Moll G, Schwartz ID, Pang S: An update to define the hormonal criteria for inherited severe and mild 3-hydroxysteroid dehydrogenase (3-HSD) deficiency disorder and hormonal expression in carriers for 3-HSD deficiency
Ensuring consistent quality and ingredient authenticity
it's startlingly fast